Metastasising ameloblastoma or ameloblastic carcinoma? A case report with mutation analyses.
Pavel HurníkBarbora Moldovan PutnováTereza ŠevčíkováEva HrubáIveta PutnováJosef ŠkardaMartin HavelOldřich ResJakub CvekMarcela BuchtováJan ŠtembírekPublished in: BMC oral health (2023)
In conclusion, we have uncovered a unique case of ameloblastic carcinoma associated with an alteration of Wnt signalling and the presence of BRAF mutation. Development of harmful state of our patient might be also supported by the germline mutation in one FANCA allele, however this has to be confirmed by further analyses.
Keyphrases